Perry Bartlett

Professor Perry Bartlett is a leading neuroscientist at the Queensland Brain Institute (University of Queensland). His research focuses on neurogenesis and stem cell biology in the adult brain, particularly in the hippocampus. He discovered that the adult brain retains neurogenic capacity, challenging earlier beliefs about its fixed structure. His work explores how exercise, growth factors, and environmental stimuli influence neural precursor activation and cognitive function in aging and neurodegenerative diseases like Alzheimer's and ALS. He currently leads a human clinical trial investigating exercise's role in mitigating dementia onset.

Education: Not explicitly listed in the provided text, but his academic career spans over four decades, including foundational work in neurobiology. Research interests include stem cell regulation, brain plasticity, and translational therapies for neurological disorders.

Research highlights include identifying hippocampal stem cell subpopulations, demonstrating exercise-induced neurogenesis, and developing EphA4 inhibitors for spinal cord injury. His lab uses mouse models and clinical trials to bridge basic science and therapeutic applications. Current grants focus on neuroprotective therapies and aging-related cognitive decline.

Labs/Teams: Leads the 'Neurogenic regulation of cognition' research group at QBI, collaborating with institutions globally on projects involving stem cell biology, clinical trials, and neurotechnology.